These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9463986)

  • 41. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption.
    Kaufman DW; Kelly JP; Wiholm BE; Laszlo A; Sheehan JE; Koff RS; Shapiro S
    Am J Gastroenterol; 1999 Nov; 94(11):3189-96. PubMed ID: 10566713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].
    Florent C; Desaint B
    Gastroenterol Clin Biol; 1989 Mar; 13(3):235-8. PubMed ID: 2731675
    [No Abstract]   [Full Text] [Related]  

  • 44. [Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].
    Rodríguez-Hernández H; Jacobo-Karam JS; Jáquez-Quintana JO; Avila-Romero HG; Galván-Román L; Lara-Miranda SC; Sánchez-Anguiano LF
    Rev Invest Clin; 2003; 55(3):254-9. PubMed ID: 14515669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Endoscopic findings of low-dose aspirin associated ulcers].
    Miyake K; Kusunoki M; Sakamoto C
    Nihon Rinsho; 2010 Nov; 68(11):2031-5. PubMed ID: 21061528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Ruszniewski P; Soufflet C; Barthélémy P
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
    Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D
    Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pill-induced esophageal injury: endoscopic features and clinical outcomes.
    Abid S; Mumtaz K; Jafri W; Hamid S; Abbas Z; Shah HA; Khan AH
    Endoscopy; 2005 Aug; 37(8):740-4. PubMed ID: 16032493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups.
    Talley NJ; Weaver AL; Zinsmeister AR
    Am J Gastroenterol; 1994 Apr; 89(4):524-8. PubMed ID: 8147354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of gastric ulcer disease by community-based gastroenterologists.
    Brazer SR; Tyor MP; Pancotto FS; Nickl NJ; Wildermann NM; Harrell FE; Pryor DB
    Am J Gastroenterol; 1990 Jul; 85(7):824-8. PubMed ID: 2371983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-inflammatory drug intake and the risk of ulcer complications.
    Langman MJ
    Med Toxicol; 1986; 1 Suppl 1():34-8. PubMed ID: 3493403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of non-steroidal anti-inflammatory drugs on upper gastrointestinal disorders in orthopaedic patients].
    Uchio Y; Mori R; Iwasa J; Kakimaru H; Yamamoto S; Yamaguchi H; Miyamoto W
    Nihon Rinsho; 2007 Oct; 65(10):1906-11. PubMed ID: 17926545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal side-effects of NSAIDs in the community.
    Jones RH; Tait CL
    Br J Clin Pract; 1995; 49(2):67-70. PubMed ID: 7779646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of non-steroidal anti-inflammatory agents on the upper gastro-intestinal tract: gastroscopic findings in Nigerians.
    Atoba MA; Olubuyide IO
    Cent Afr J Med; 1989 Jul; 35(7):427-30. PubMed ID: 2582486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls.
    Sheikh RA; Romano PS; Prindiville TP; Yasmeen S; Trudeau W
    J Clin Gastroenterol; 2002; 34(5):529-32. PubMed ID: 11960063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.